Genetic Technology News

摘要

Migenix Clinical Trial for CNS Disease Agent; Parattele Searches for More Gene Disease Links; Amylin and Lilly Get Diabetes Drug OK; GTN Strategic Partners; Biotech Financing; Some Important Patents for You To Check; ACHILLION FIGHTS HIV BY BLOCKING CAPSID FORMATION: Particles of HIV are surrounded by a protective capsid. This protein coating the virus is essential to its infectivity. Achillion Pharmaceuticals Inc. has chosen capsid formation inhibition as an approach to treating retroviral diseases.The National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) has made a Phase I Small Business Innovation Research grant to Achillion to support the company's program for identifying small-molecule HTV capsid assembly inhibitors, and to further characterize capsid inhibition as a method of HIV treatment.